OptimizeRx Corp (OPRX)
7.75
+0.22
(+2.92%)
USD |
NASDAQ |
Sep 27, 16:00
7.74
-0.01
(-0.13%)
After-Hours: 20:00
OptimizeRx SG&A Expense (Annual): 58.02M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 58.02M |
| December 31, 2022 | 49.24M |
| December 31, 2021 | 33.19M |
| December 31, 2020 | 23.35M |
| December 31, 2019 | 14.56M |
| December 31, 2018 | 10.29M |
| December 31, 2017 | 6.749M |
| December 31, 2016 | 5.238M |
| Date | Value |
|---|---|
| December 31, 2015 | 3.322M |
| December 31, 2014 | 3.454M |
| December 31, 2013 | 2.811M |
| December 31, 2012 | 2.142M |
| December 31, 2011 | 2.420M |
| December 31, 2010 | 1.917M |
| December 31, 2009 | 4.541M |
| December 31, 2008 | 1.466M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
14.56M
Minimum
2019
58.02M
Maximum
2023
35.67M
Average
33.19M
Median
2021
SG&A Expense (Annual) Benchmarks
| Regional Health Properties Inc | 3.976M |
| Amedisys Inc | 780.06M |
| Addus HomeCare Corp | 234.79M |
| Health Catalyst Inc | 143.88M |
| Option Care Health Inc | 607.43M |